Efficacy and tolerability of moxidectin alone and in co-administration with albendazole and tribendimidine versus albendazole plus oxantel pamoate against Trichuris trichiura infections: a randomised, non-inferiority, single-blind trial

The Lancet Infectious Diseases

Volumn 18, Issue 8, 2018, Pages 864-873

  Barda, Beatrice ^a   Ame, Shaali M ^c   Ali, Said M ^c   Albonico, Marco ^d   Puchkov, Maxim ^b   Huwyler, Jörg ^b   Hattendorf, Jan ^a   Keiser, Jennifer ^a  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c Public Health Laboratory   (Tanzania)

^d SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; MOXIDECTIN; OXANTEL EMBONATE; TRIBENDIMIDINE; UNCLASSIFIED DRUG; MACROLIDE; MEBENDAZOLE; MILBEMYCIN; PHENYLENEDIAMINE DERIVATIVE; PYRANTEL EMBONATE;

ADOLESCENT; ARTICLE; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HEADACHE; HIGH SCHOOL; HUMAN; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIMARY SCHOOL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; STOMACH PAIN; TANZANIA; TREATMENT OUTCOME; TREATMENT RESPONSE; TRICHURIASIS; ANALOGS AND DERIVATIVES; ANIMAL; CHILD; COMBINATION DRUG THERAPY; ISOLATION AND PURIFICATION; ORAL DRUG ADMINISTRATION; SINGLE BLIND PROCEDURE; TRICHURIS;

ADMINISTRATION, ORAL; ADOLESCENT; ALBENDAZOLE; ANIMALS; ANTHELMINTICS; CHILD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MACROLIDES; MALE; MEBENDAZOLE; PHENYLENEDIAMINES; PYRANTEL PAMOATE; SINGLE-BLIND METHOD; TRICHURIASIS; TRICHURIS;

EID: 85047521772     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(18)30233-0     Document Type: Article

References (27)

1. Pullan, RL, Smith, JL, Jasrasaria, R, Brooker, SJ, Global numbers of infection and disease burden of soil transmitted helminth infections in 2010. Parasit Vectors, 7, 2014, 37.
2. Hotez, PJ, Fenwick, A, Savioli, L, Molyneux, DH, Rescuing the bottom billion through control of neglected tropical diseases. Lancet 373 (2009), 1570–1575.
3. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388 (2016), 1603–1658.
4. Jourdan, PM, Lamberton, PHL, Fenwick, A, Addiss, DG, Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet 391 (2018), 252–265.
5. Moser, W, Schindler, C, Keiser, J, Efficacy of recommended drugs against soil transmitted helminths: systematic review and network meta-analysis. BMJ, 358, 2017, j4307.
6. Lo, NC, Addiss, DG, Hotez, PJ, et al. A call to strengthen the global strategy against schistosomiasis and soil-transmitted helminthiasis: the time is now. Lancet Infect Dis 17 (2017), e64–e69.
7. WHO. Guideline: preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups. 2017, World Health Organization, Geneva.
8. Albonico, M, Allen, H, Chitsulo, L, Engels, D, Gabrielli, A-F, Savioli, L, Controlling soil-transmitted helminthiasis in pre-school-age children through preventive chemotherapy. PLoS Negl Trop Dis, 2, 2008, e126.
9. Lo, NC, Lai, Y-S, Karagiannis-Voules, D-A, et al. Assessment of global guidelines for preventive chemotherapy against schistosomiasis and soil-transmitted helminthiasis: a cost-effectiveness modelling study. Lancet Infect Dis 16 (2016), 1065–1075.
10. Speich, B, Ame, SM, Ali, SM, et al. Oxantel pamoate-albendazole for Trichuris trichiura infection. N Engl J Med 370 (2014), 610–620.
11. Abdelraouf, K, Linder, KE, Nailor, MD, Nicolau, DP, Predicting and preventing antimicrobial resistance utilizing pharmacodynamics: part II Gram-negative bacteria. Expert Opin Drug Metab Toxicol 13 (2017), 705–714.
12. Canton, C, Ceballos, L, Fiel, C, et al. Resistant nematodes in cattle: Pharmaco-therapeutic assessment of the ivermectin-ricobendazole combination. Vet Parasitol 234 (2017), 40–48.
13. Korth-Bradley, JM, Parks, V, Patat, A, Matschke, K, Mayer, P, Fleckenstein, L, Relative bioavailability of liquid and tablet formulations of the antiparasitic moxidectin. Clin Pharmacol Drug Dev 1 (2012), 32–37.
14. Opoku, NO, Bakajika, DK, Kanza, EM, et al. Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial. Lancet, 2018 published online Jan 17. http://dx.doi.org/10.1016/S0140-6736(17)32844-1.
15. Prichard, R, Ménez, C, Lespine, A, Moxidectin and the avermectins: consanguinity but not identity. Int J Parasitol Drugs Drug Resist 2 (2012), 134–153.
16. Bygarski, EE, Prichard, RK, Ardelli, BF, Resistance to the macrocyclic lactone moxidectin is mediated in part by membrane transporter P-glycoproteins: implications for control of drug resistant parasitic nematodes. Int J Parasitol Drugs Drug Resist 4 (2014), 143–151.
17. Forrester, SG, Prichard, RK, Beech, RN, A glutamate-gated chloride channel subunit from Haemonchus contortus: expression in a mammalian cell line, ligand binding, and modulation of anthelmintic binding by glutamate. Biochem Pharmacol 63 (2002), 1061–1068.
18. Barda, B, Sayasone, S, Phongluxa, K, et al. Efficacy of moxidectin versus ivermectin against Strongyloides stercoralis infections: a randomized, controlled noninferiority trial. Clin Infect Dis 65 (2017), 276–281.
19. Barda, B, Coulibaly, JT, Puchkov, M, Huwyler, J, Hattendorf, J, Keiser, J, Efficacy and safety of moxidectin, synriam, synriam-praziquantel versus praziquantel against Schistosoma haematobium and S mansoni infections: a randomized, exploratory phase 2 trial. PLoS Negl Trop Dis, 10, 2016, e0005008.
20. Korth-Bradley, JM, Parks, V, Chalon, S, et al. The effect of a high-fat breakfast on the pharmacokinetics of moxidectin in healthy male subjects: a randomized phase I trial. Am J Trop Med Hyg 86 (2012), 122–125.
21. Moser, W, Coulibaly, JT, Ali, SM, et al. Efficacy and safety of tribendimidine, tribendimidine plus ivermectin, tribendimidine plus oxantel pamoate, and albendazole plus oxantel pamoate against hookworm and concomitant soil-transmitted helminth infections in Tanzania and Côte d'Ivoire: a randomised, controlled, single-blinded, non-inferiority trial. Lancet Infect Dis 17 (2017), 1162–1171.
22. Moser, W, Ali, SM, Ame, SM, et al. Efficacy and safety of oxantel pamoate in school-aged children infected with Trichuris trichiura on Pemba Island, Tanzania: a parallel, randomised, controlled, dose-ranging study. Lancet Infect Dis 16 (2016), 53–60.
23. Wagner-Hattler, L, Wyss, K, Schoelkopf, J, Huwyler, J, Puchkov, M, In vitro characterization and mouthfeel study of functionalized calcium carbonate in orally disintegrating tablets. Int J Pharm 534 (2017), 50–59.
24. Speich, B, Ali, SM, Ame, SM, Albonico, M, Utzinger, J, Keiser, J, Quality control in the diagnosis of Trichuris trichiura and Ascaris lumbricoides using the Kato-Katz technique: experience from three randomised controlled trials. Parasit Vectors, 8, 2015, 82.
25. Alvarez, L, Lifschitz, A, Entrocasso, C, et al. Evaluation of the interaction between ivermectin and albendazole following their combined use in lambs. J Vet Pharmacol Ther 31 (2008), 230–239.
26. Kiki-Mvouaka, S, Ménez, C, Borin, C, et al. Role of p-glycoprotein in the disposition of macrocyclic lactones: a comparison between ivermectin, eprinomectin, and moxidectin in mice. Drug Metab Dispos Biol Fate Chem 38 (2010), 573–580.
27. Perez, M, Blazquez, AG, Real, R, et al. In vitro and in vivo interaction of moxidectin with BCRP/ABCG2. Chem Biol Interact 180 (2009), 106–112.